Cargando…
Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda
BACKGROUND: Neisseria meningitidis serogroup A is the main causative pathogen of meningitis epidemics in sub-Saharan Africa. In recent years, serogroup W135 has also been the cause of epidemics. Mass vaccination campaigns with polysaccharide vaccines are key elements in controlling these epidemics....
Autores principales: | Guerin, Philippe J., Næss, Lisbeth M., Fogg, Carole, Rosenqvist, Einar, Pinoges, Loretxu, Bajunirwe, Francis, Nabasumba, Carolyn, Borrow, Ray, Frøholm, Leif O., Ghabri, Salah, Batwala, Vincent, Twesigye, Rogers, Aaberge, Ingeborg S., Røttingen, John-Arne, Piola, Patrice, Caugant, Dominique A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584372/ https://www.ncbi.nlm.nih.gov/pubmed/19048025 http://dx.doi.org/10.1371/journal.pntd.0000342 |
Ejemplares similares
-
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
por: Holst, Johan, et al.
Publicado: (2013) -
Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008) -
Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
por: Watle, Sara Viksmoen, et al.
Publicado: (2021) -
W135 Meningococcal Disease in Africa
por: Pollard, Andrew J., et al.
Publicado: (2003) -
The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: A randomized, controlled non-inferiority study
por: Dbaibo, Ghassan, et al.
Publicado: (2012)